Evidence map›Paper›PMID 40042879›Full record

ArticleEuropean journal of preventive cardiology2026

The association of childhood HDL cholesterol with atherosclerotic cardiovascular disease events in adults: findings from the International Childhood Cardiovascular Cohort Consortium.

Jing Wang, Noora Kartiosuo, Olli T Raitakari, Jorma Viikari, Markus Juonala, Lydia A Bazzano, Alan R Sinaiko, Julia Steinberger, Stephen R Daniels, Alison J Venn and 7 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jing WangMurdoch Children's Research Institute, The Royal Children's Hospital, 50 Flemington Road, Parkville, Victoria 3052, Australia.ORCID 0000-0001-5701-476X
Noora KartiosuoCentre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.
Olli T RaitakariCentre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.
Jorma ViikariDepartment of Medicine, University of Turku and Turku University Hospital, Turku, Finland.
Markus JuonalaDepartment of Medicine, University of Turku and Turku University Hospital, Turku, Finland.ORCID 0000-0001-9498-364X
Lydia A BazzanoSchool of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Alan R SinaikoDepartment of Pediatrics, Division of Pediatric Nephrology, University of Minnesota, Minneapolis, MN, USA.
Julia SteinbergerDepartment of Pediatrics, Division of Pediatric Cardiology, University of Minnesota, Minneapolis, MN, USA.
Stephen R DanielsDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
Alison J VennMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Costan MagnussenCentre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.
Jessica G WooCincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA.
Rema RamakrishnanNuffield Department of Women's & Reproductive Health, Women's Centre, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Elaine M UrbinaCincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA.
Mika KähönenDepartment of Clinical Physiology, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.
David R JacobsDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-7232-0543
Terence DwyerMurdoch Children's Research Institute, The Royal Children's Hospital, 50 Flemington Road, Parkville, Victoria 3052, Australia.ORCID 0000-0002-2091-7663

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BRYAN C BERGMAN · 1995 to 2026
$32.6M
Childhood CV Risk and Adult CVD Outcomes: an International Long-term Follow-upR01HL121230 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BURNS, TRUDY L, CHEN, WEI · 2015 to 2019
$13.3M
AIHWAustralian Institute of Health and WelfareAustralian National Death IndexData Integration Services CentreNHLBI NIH HHS R01 HL121230NIDDK NIH HHS P30 DK048520NIH HHS HL121230
6 · The paper itself

Abstract

aimsThe role of adult HDL-C in atherosclerotic cardiovascular disease (ASCVD) faces challenges from Mendelian randomizations and drug trials. However, the association between childhood HDL-C and its changes and adult ASCVD remains undefined. This study aimed to determine this association. METHODS AND

resultsParticipants: Children in the International Childhood Cardiovascular Cohort (i3C) Consortium with childhood HDL-C and adult ASCVD follow-up. Age- and sex-standardized HDL-C z-scores were calculated for childhood (3-19 years), early childhood (3-11 years), and adolescence (12-19 years); low HDL-C defined as <1.03 mmol/L; participants classified as consistently normal, low to normal, normal to low, and consistently low based on HDL-C status at early childhood and adolescence. ASCVD events: Identified using self-reports adjudicated by medical records or death registries. Analysis: Cox proportional hazards models quantified the associations between childhood HDL-C and adult ASCVD. The study included 38 589 participants (49.7% males, mean age in 2016: 46.4 years) with 779 ASCVD and 784 imputed ASCVD events. After adjusting for sex, cohort, age, and HDL-C measurement year, higher HDL-C z-scores in childhood, early childhood, and adolescence were associated with lower adult ASCVD risk [hazard ratio (HR): 0.81-0.82], with the lowest risk at HDL-C > 1.50 mmol/L. Normal to low [HR 1.38, 95% confidence intervaI (CI) 1.04-1.82] and consistently low (HR 1.94, 95% CI 1.45-2.63) childhood HDL-C increased adult ASCVD risk compared to consistently normal HDL-C. Adjusting for body mass index and triglycerides weakened these associations.

conclusionChildhood and adolescent HDL-C were prospectively and inversely associated with adult ASCVD, suggesting that low HDL-C could be a risk marker of adult ASCVD. Future replications, mechanistic studies, and Mendelian randomizations on childhood HDL-C may clarify its causal effects on adult ASCVD. LAY SUMMARY: We examined the association between childhood HDL-C measurement and adult atherosclerotic cardiovascular disease (ASCVD) at follow-up in data from the International Childhood Cardiovascular Cohort (i3C) Consortium.Higher HDL-C levels in childhood were associated with lower risk of a ASCVD event, irrespective of age (early childhood vs. adolescence). The lowest risk was observed at HDL-C concentrations of around and above 1.50 mmol/L (58 mg/dL). A decrease in HDL-C from early childhood to adolescence was associated with an increased risk of adult ASCVD.When additionally adjusted for body mass index z-score, attenuated associations were noted. Adding triglycerides to models attenuated associations towards null.

Indexed as

AtherosclerosisCholesterol, HDLDyslipidemiasAdolescentAdultAge FactorsBiomarkersChildChild, PreschoolFemaleHumansIncidenceMaleMiddle AgedPrognosisRisk AssessmentBiomarkersCholesterol, HDLAdult ASCVDChildhood HDL-CCohort studyCox proportional hazardsRisk factors

Identifiers

PMID40042879
PMCPMC12892258

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.